Despite promise, Turing pharmaceuticals opts to keep list price of Daraprim high
Wednesday, November 25, 2015 - 17:10
in Health & Medicine
Doug G. WareNEW YORK, Nov. 25 (UPI) -- Despite a pledge two months ago, Turing Pharmaceuticals said Wednesday it won't cut the list price of a drug used for infections associated with cancer and HIV.